A technology has been developed that can analyze tumor mutations in lung cancer patients to confirm drug resistance to ...

Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...

Imatinib oral solution has gained FDA approval for the treatment of some cancers, including certain forms of leukemia.

The approval is based on the Phase II LITESPARK-004 trial's objective response rate and median duration of response outcomes.

In line with the proposal for amending the warning statement of Insulin Lispro Ultrarapid Injection 100 IU & 200 IU, the ...

Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) have earned an average recommendation of “Moderate Buy” from the seven research firms that are currently covering the firm, ...

Commercial, Clinical and Regulatory Expertise Establish Clearside as the Leader in Suprachoroidal Delivery -- Multiple Events at Asia-Pacific ...

Tumor cells transform fibroblasts into cancer-associated fibroblasts, which have an important immunosuppressive activity on which growth, invasion, and metastasis depend. These activated fibroblasts ...

Principal Financial Group Inc. lowered its position in shares of Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 49.2% in the 3rd quarter, according to its most recent Form 13F filing with the ...